IL-18 administration in sepsis increased IL-17A production by murine intestinal γδ T cells as well as Ly6G+ myeloid cells, and blocking IL-17A reduced IL-18-potentiated mortality in both neonatal sepsis and endotoxemia. The gene discussed is IL18; the disease is Sepsis.